Menu
  • Join
  • Login
  • Contact
 

Search abstracts


GRANTING BIOWAIVER FOR IMMEDIATE RELEASE SOLID ORAL DOSAGE FORMS OF AMOXICILLIN: RESULTS OF A LITERATURE REVIEW

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: THAMBAVITA, Dhanusha (Faculty of Medicine, University of Colombo, Pharmacology, Colombo-08, Sri Lanka)
  • Co-author(s): Dhanusha Thambavita
  • Abstract:

    Biowaiver(BW) monographs pertaining to waiving of in vivo bioequivalence(BE) are available for drugs belonging to Biopharmaceutics Classification System(BCS) class 1 and III. World Health Organization(WHO) classifies amoxicillin to BCS class 1 but no BW monograph is available as yet. We reviewed literature relevant to a BW monograph for..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses